β-Ionone represses renal cell carcinoma progression through activating LKB1/AMPK-triggered autophagy

J Biochem Mol Toxicol. 2023 Jun;37(6):e23331. doi: 10.1002/jbt.23331. Epub 2023 Feb 26.

Abstract

β-Ionone, the end ring analog of β-carotenoids, has been proven to have an antitumor effect in a variety of cancers. In this study, we investigated the impact of β-ionone on renal cell carcinoma (RCC) cell lines (786-O and ACHN) using colony formation assays, flow cytometry analysis, and western blot analysis. We found that β-ionone effectively inhibited the proliferation of RCC cells in vitro, which was also confirmed in a xenograft model. Moreover, we found that β-ionone could induce autophagy, as indicated by LC3 puncta in 786-O and ACHN cell lines and the expression of LC3 in β-ionone-treated RCC cells. To further explore the underlying mechanism, we assessed liver kinase B1/AMP-activated protein kinase (LKB1/AMPK) signaling pathway activity, and the results showed that β-ionone inhibited the proliferation of RCC cells by inducing autophagy via the LKB1/AMPK signaling pathway. In summary, our findings provide a new therapeutic strategy of β-ionone-induced autophagy in RCC.

Keywords: LKB1/AMPK; autophagy; proliferation; renal cancer cell; β-Ionone.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Autophagy
  • Carcinoma, Renal Cell* / drug therapy
  • Carcinoma, Renal Cell* / metabolism
  • Cell Line, Tumor
  • Cell Proliferation
  • Humans
  • Kidney Neoplasms* / metabolism
  • Protein Serine-Threonine Kinases / metabolism

Substances

  • AMP-Activated Protein Kinases
  • beta-ionone
  • Protein Serine-Threonine Kinases